| A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? S Adeberg, T Bostel, L König, T Welzel, J Debus, SE Combs Radiation oncology 9, 1-6, 2014 | 171 | 2014 |
| Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone S Adeberg, L König, T Bostel, S Harrabi, T Welzel, J Debus, SE Combs International Journal of Radiation Oncology* Biology* Physics 90 (4), 886-893, 2014 | 121 | 2014 |
| Intensity modulated radiation therapy (IMRT) with simultaneously integrated boost shortens treatment time and is noninferior to conventional radiation therapy followed by … J Hörner-Rieber, T Forster, A Hommertgen, MF Haefner, N Arians, ... International Journal of Radiation Oncology* Biology* Physics 109 (5), 1311-1324, 2021 | 52 | 2021 |
| Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients L König, MF Häfner, S Katayama, SA Koerber, E Tonndorf-Martini, ... Radiation Oncology 15, 1-9, 2020 | 50 | 2020 |
| Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy J Hörner-Rieber, D Bernhardt, J Dern, L König, S Adeberg, A Paul, ... Radiotherapy and Oncology 125 (2), 317-324, 2017 | 47 | 2017 |
| Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy D Bernhardt, S Adeberg, F Bozorgmehr, N Opfermann, J Hoerner-Rieber, ... Journal of neuro-oncology 134, 205-212, 2017 | 45 | 2017 |
| Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy D Bernhardt, S Aufderstrasse, L König, S Adeberg, F Bozorgmehr, ... Cancer management and research, 6563-6569, 2018 | 40 | 2018 |
| Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation D Bernhardt, F Bozorgmehr, S Adeberg, N Opfermann, D von Eiff, ... Lung Cancer 101, 76-81, 2016 | 40 | 2016 |
| Radiotherapy of indolent orbital lymphomas L König, R Stade, J Rieber, J Debus, K Herfarth Strahlentherapie und Onkologie 192 (6), 414, 2016 | 36 | 2016 |
| Magnetic resonance-guided stereotactic body radiotherapy of liver tumors: initial clinical experience and patient-reported outcomes F Weykamp, P Hoegen, S Klüter, CK Spindeldreier, L König, ... Frontiers in oncology 11, 610637, 2021 | 34 | 2021 |
| Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer-study protocol of the FORCE trial F Bozorgmehr, A Hommertgen, J Krisam, F Lasitschka, J Kuon, M Maenz, ... BMC cancer 19, 1-11, 2019 | 32 | 2019 |
| Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis D Buergy, F Würschmidt, E Gkika, J Hörner‐Rieber, S Knippen, S Gerum, ... International journal of cancer 149 (2), 358-370, 2021 | 31 | 2021 |
| Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma MF Haefner, V Verma, N Bougatf, T Mielke, E Tonndorf-Martini, L König, ... Acta Oncologica 57 (12), 1713-1720, 2018 | 30 | 2018 |
| Outcome and prognostic factors in single brain metastases from small-cell lung cancer D Bernhardt, S Adeberg, F Bozorgmehr, N Opfermann, J Hörner-Rieber, ... Strahlentherapie und Onkologie 194 (2), 98-106, 2018 | 30 | 2018 |
| Whole brain radiation therapy alone versus radiosurgery for patients with 1–10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized … D Bernhardt, A Hommertgen, D Schmitt, R El Shafie, A Paul, L König, ... Trials 19, 1-8, 2018 | 29 | 2018 |
| Extracranial stereotactic body radiotherapy in oligometastatic or oligoprogressive breast cancer F Weykamp, L König, K Seidensaal, T Forster, P Hoegen, S Akbaba, ... Frontiers in Oncology 10, 987, 2020 | 27 | 2020 |
| Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas L König, J Hörner-Rieber, D Bernhardt, A Hommertgen, S Rieken, ... Strahlentherapie und Onkologie 194 (5), 454-461, 2018 | 26 | 2018 |
| Cone-beam-CT guided adaptive radiotherapy for locally advanced non-small cell lung cancer enables quality assurance and superior sparing of healthy lung P Hoegen, C Lang, S Akbaba, P Häring, M Splinter, A Miltner, ... Frontiers in oncology 10, 564857, 2020 | 24 | 2020 |
| Metformin enhanced radiosensitivity associates with G2/M cell cycle arrest and elevated adenosine-5’-monophosphate-activated protein kinase levels in glioblastoma S Adeberg, D Bernhardt, SB Harrabi, NH Nicolay, J Hörner-Rieber, ... Radiology and oncology 51 (4), 431-437, 2017 | 24 | 2017 |
| Adaptive MR-guided stereotactic radiotherapy is beneficial for ablative treatment of lung tumors in high-risk locations S Regnery, C Buchele, F Weykamp, M Pohl, P Hoegen, T Eichkorn, ... Frontiers in oncology 11, 757031, 2022 | 23 | 2022 |
